Assessment of the Effect of Age on the Immunological and Virological Response to a Live Attentuated Influenza Vaccine for the 2009 H1N1 Virus
Phase of Trial: Phase I/II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- 26 Apr 2016 Time frame for primary endpoint changed from 'days 2,5, and 7' to 'day 0 to day 7 post vaccination'.
- 02 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.